Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hepatocellular carcinoma
(
HCC
) contributes to cancer-related deaths greatly every year in the world. However, there is still no radical method for
HCC
treatment. Here we screened out a lncRNA FABP5P3 that was up-regulated in
HCC
tissues. Patients with higher FABP5P3 expression displayed poorer survival rate. FABP5P3 depletion in
HCC
cell lines and sample cells remarkably inhibited the abilities of proliferation, migration and invasion. In mechanism, we showed that FABP5P3 bond to miR-589-5p which served as a tumor suppressor. MiR-589-5p targeted directly the mRNA of
ZMYND19
whose function has not been defined in
HCC
. FABP5P3 promoted
HCC
development and progression by sponging miR-589-5p and up-regulating
ZMYND19
expression. In sum, we showed that FABP5P3/miR-589-5p/
ZMYND19
axis regulates cell proliferation and migration in
HCC
, which may serve as a new target for
HCC
treatment.
...
PMID:LncRNA FABP5P3/miR-589-5p/ZMYND19 axis contributes to hepatocellular carcinoma cell proliferation, migration and invasion. 2952 15